BACKGROUND: An effective immune system, especially during the inflammatory phase, putatively influences the quality and likelihood of bone healing. If and how this is reflected within the initial fracture hematoma is unclear. QUESTIONS/PURPOSES: We therefore asked the following questions: (1) Does the local expression in fracture hematoma of genes involved in adaptation to hypoxia, migration, angiogenesis, and osteogenesis vary as compared to the peripheral blood? (2) Do these changes occur time dependently? (3) Is the gene expression during fracture hematoma formation altered by irradiation? METHODS: Cells from fracture hematoma of 20 patients and hematomas formed in 40 patients after THA (20 without and 20 with preoperative radiation) were isolated and RNA was extracted to analyze the influence of oxygen deprivation during fracture healing on mRNA expression of genes (HIF1A, LDHA, and PGK1) involved in immunoregulation (IL6, IL8, CXCR4), angiogenesis (VEGF, IL8), and osteogenesis (SPP1, RUNX2) by quantitative PCR. RESULTS: We observed locally increased LDHA gene expression in fracture hematoma cells (6-72 h post fracture) reflecting the adaptation to hypoxia. IL6, IL8, and VEGF upregulation indicated hypoxia-mediated inflammation and angiogenesis; increased CXCR4 expression reflected immigration of immune cells. Osteogenic differentiation was reflected in the increased expression of the SPP1 and RUNX2 genes. The increased expression of the LDHA, VEGF, IL8, SPP1 and RUNX2 genes occurred time dependently. Irradiation suppressed HIF1A, IL6, IL8, CXCR4, and RUNX2 gene expression. CONCLUSIONS: Our data suggest cells in the fracture hematoma (1) adapt to hypoxia and (2) promote inflammation in fracture healing at the mRNA level, indicating early involvement of the immune system. CLINICAL RELEVANCE: The initial fracture hematoma is important for the onset of angiogenesis, chemotaxis, and osteogenesis.
BACKGROUND: An effective immune system, especially during the inflammatory phase, putatively influences the quality and likelihood of bone healing. If and how this is reflected within the initial fracture hematoma is unclear. QUESTIONS/PURPOSES: We therefore asked the following questions: (1) Does the local expression in fracture hematoma of genes involved in adaptation to hypoxia, migration, angiogenesis, and osteogenesis vary as compared to the peripheral blood? (2) Do these changes occur time dependently? (3) Is the gene expression during fracture hematoma formation altered by irradiation? METHODS: Cells from fracture hematoma of 20 patients and hematomas formed in 40 patients after THA (20 without and 20 with preoperative radiation) were isolated and RNA was extracted to analyze the influence of oxygen deprivation during fracture healing on mRNA expression of genes (HIF1A, LDHA, and PGK1) involved in immunoregulation (IL6, IL8, CXCR4), angiogenesis (VEGF, IL8), and osteogenesis (SPP1, RUNX2) by quantitative PCR. RESULTS: We observed locally increased LDHA gene expression in fracture hematoma cells (6-72 h post fracture) reflecting the adaptation to hypoxia. IL6, IL8, and VEGF upregulation indicated hypoxia-mediated inflammation and angiogenesis; increased CXCR4 expression reflected immigration of immune cells. Osteogenic differentiation was reflected in the increased expression of the SPP1 and RUNX2 genes. The increased expression of the LDHA, VEGF, IL8, SPP1 and RUNX2 genes occurred time dependently. Irradiation suppressed HIF1A, IL6, IL8, CXCR4, and RUNX2 gene expression. CONCLUSIONS: Our data suggest cells in the fracture hematoma (1) adapt to hypoxia and (2) promote inflammation in fracture healing at the mRNA level, indicating early involvement of the immune system. CLINICAL RELEVANCE: The initial fracture hematoma is important for the onset of angiogenesis, chemotaxis, and osteogenesis.
Authors: Thorsten Cramer; Yuji Yamanishi; Björn E Clausen; Irmgard Förster; Rafal Pawlinski; Nigel Mackman; Volker H Haase; Rudolf Jaenisch; Maripat Corr; Victor Nizet; Gary S Firestein; Hans Peter Gerber; Napoleone Ferrara; Randall S Johnson Journal: Cell Date: 2003-03-07 Impact factor: 41.582
Authors: Kazuhisa Nakashima; Xin Zhou; Gary Kunkel; Zhaoping Zhang; Jian Min Deng; Richard R Behringer; Benoit de Crombrugghe Journal: Cell Date: 2002-01-11 Impact factor: 41.582
Authors: Paula Kolar; Katharina Schmidt-Bleek; Hanna Schell; Timo Gaber; Daniel Toben; Gerhard Schmidmaier; Carsten Perka; Frank Buttgereit; Georg N Duda Journal: Tissue Eng Part B Rev Date: 2010-08 Impact factor: 6.389
Authors: Timo Gaber; Thomas Häupl; Grit Sandig; Karolina Tykwinska; Monique Fangradt; Miriam Tschirschmann; Martin Hahne; René Dziurla; Kerem Erekul; Martin Lautenbach; Paula Kolar; Gerd-Rüdiger Burmester; Frank Buttgereit Journal: J Rheumatol Date: 2009-11-02 Impact factor: 4.666
Authors: Petra Klein; Hanna Schell; Florian Streitparth; Markus Heller; Jean-Pierre Kassi; Frank Kandziora; Hermann Bragulla; Norbert P Haas; Georg N Duda Journal: J Orthop Res Date: 2003-07 Impact factor: 3.494
Authors: John H Hebb; Jason W Ashley; Lee McDaniel; Luke A Lopas; John Tobias; Kurt D Hankenson; Jaimo Ahn Journal: J Orthop Res Date: 2017-10-09 Impact factor: 3.494
Authors: Brett S Klosterhoff; Melissa Tsang; Didi She; Keat Ghee Ong; Mark G Allen; Nick J Willett; Robert E Guldberg Journal: J Biomech Eng Date: 2017-02-01 Impact factor: 2.097
Authors: Paula Hoff; T Gaber; K Schmidt-Bleek; U Sentürk; C L Tran; K Blankenstein; S Lütkecosmann; J Bredahl; H J Schüler; P Simon; G Wassilew; F Unterhauser; G R Burmester; G Schmidmaier; C Perka; G N Duda; F Buttgereit Journal: Immunol Res Date: 2011-10 Impact factor: 2.829
Authors: Paula Hoff; T Gaber; C Strehl; K Schmidt-Bleek; A Lang; D Huscher; G R Burmester; G Schmidmaier; C Perka; G N Duda; F Buttgereit Journal: Immunol Res Date: 2016-12 Impact factor: 2.829
Authors: Soenke Percy Frey; Stefanie Doht; Lars Eden; Stefan Dannigkeit; Norbert Schuetze; Rainer H Meffert; Hendrik Jansen Journal: Int Orthop Date: 2012-09-23 Impact factor: 3.075